Millions of people desperate to lose weight want to take Wegovy or its sister drug Ozempic

Insurers are using prior authorization and other managed care strategies to control costs associated with the growing number of prescriptions, on- and off-label, for the weight-loss medications

Real-world data show higher treatment persistence among patients using Wegovy compared with older weight-loss medications

Real-world data show many patients discontinue weight-loss medications within the first year